Publications by authors named "Michael Bengtson"

Claim this Profile
C
Common Factors in Pediatric Psychiatry: A Review of Essential and Adjunctive Mechanisms of Treatment Outcome.
Alessandro S De Nadai, Marc S Karver, Tanya K Murphy, Mark A Cavitt, Jeffrey L Alvaro, Michael Bengtson

J Child Adolesc Psychopharmacol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Autoepitope within the Extracellular Region of Contactin-Associated Protein-like 2 in Mice.
Demian F Obregon, Yuyan Zhu, Antoinette R Bailey, Samantha M Portis, Huayan Hou, Michael A Bengtson

Br J Med Med Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the Florida Medicaid prior-authorization program on use of antipsychotics by children under age six.
Robert Constantine, Michael A Bengtson, Tanya Murphy, Marie McPherson, Ross Andel

Psychiatr Serv· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant T-lymphocyte development and function in mice overexpressing human soluble amyloid precursor protein-α: implications for autism.
Antoinette R Bailey, Huayan Hou, Demian F Obregon, Jun Tian, Yuyan Zhu, Michael Bengtson

FASEB J· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to antipsychotic medications over a 4-year period among children who initiated antipsychotic treatment before their sixth birthday.
Robert J Constantine, Susan Jentz, Michael Bengtson, Marie McPherson, Ross Andel

Pharmacoepidemiol Drug Saf· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
Eric A Storch, Tanya K Murphy, Wayne K Goodman, Gary R Geffken, Adam B Lewin, Michael Bengtson

Biol Psychiatry· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open label aripiprazole in the treatment of youth with tic disorders.
Tanya K Murphy, P Jane Mutch, Jeannette M Reid, Paula J Edge, Eric A Storch, Michael Bengtson

J Child Adolesc Psychopharmacol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose dysregulation among veterans living with schizophrenia-related disorders after switching second-generation antipsychotics.
L Douglas Ried, Babette Brumback, Michael A Bengtson, Patrick M Garman, Chienning Hsu

J Am Pharm Assoc (2003)· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population.
Chienning Hsu, L Douglas Ried, Michael A Bengtson, Patrick M Garman, Joel R McConkey

J Am Pharm Assoc (2003)· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identical neural risk factors predict cognitive deficit in dyslexia and schizophrenia.
Christiana M Leonard, John M Kuldau, Leeza Maron, Nikki Ricciuti, Bryan Mahoney, Michael Bengtson

Neuropsychology· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia.
Patrick M Garman, L Douglas Ried, Michael A Bengtson, Chienning Hsu, Joel R McConkey

J Am Pharm Assoc (2003)· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Eric A Storch, Lisa J Merlo, Michael Bengtson, Tanya K Murphy, Mark H Lewis

Int Clin Psychopharmacol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight and blood pressure changes after switching second-generation antipsychotics in a population of veterans with schizophrenia-related disorders.
L Douglas Ried, Joel R McConkey, Michael A Bengtson, Patrick M Garman, Chienning Hsu

J Am Pharm Assoc (2003)· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased cardiovascular risk with second-generation antipsychotic agent switches.
L Douglas Ried, Bernard T Renner, Joel R McConkey, Michael A Bengtson, Larry M Lopez

J Am Pharm Assoc (2003)· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case series on the use of aripiprazole for Tourette syndrome.
Tanya K Murphy, Michael A Bengtson, Ohel Soto, Paula J Edge, Muhammad W Sajid

Int J Neuropsychopharmacol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight change after an atypical antipsychotic switch.
L Douglas Ried, Bernard T Renner, Michael A Bengtson, Brian M Wilcox, Wilfred W Acholonu

Ann Pharmacother· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis